Lifecycle of a Medical Device in Korea
Regulatory journey
1. Scope determination — Medical Devices Act or IVD Act?
2. Classification — Grade I/II/III/IV (or A/B/C/D for IVDs)
3. Business licensing — manufacturer licence or importer licence
4. KGMP certification — domestic on-site inspection or foreign GMP recognition
5. Technical documentation (STED) — device description, testing, risk, clinical data
6. Pre-market submission
├─ Grade III/IV: 품목허가 (Marketing Authorization)
└─ Grade I/II: 품목신고 (Notification)
7. UDI-K registration in KIMS
8. Korean-language labelling applied
9. Market supply
10. Post-market obligations (ongoing)
├─ Adverse event reporting
├─ Post-market surveillance
├─ Re-examination (Grade III/IV — after 3–5 years)
└─ Maintain KGMP, licences, UDI-K records
Typical timelines
| Step | Duration |
|---|---|
| KGMP certification (domestic) | 3–6 months |
| Foreign GMP recognition | 3–9 months |
| 품목허가 Grade III | 3–6 months |
| 품목허가 Grade IV | 6–12 months |
| 품목신고 | 1–4 weeks |
3.5. Korean agent appointment — Foreign manufacturers must appoint a 한국 대리인 (Korean agent) to serve as local representative for all regulatory communications. The Korean agent must be registered with MFDS and may be held jointly liable for compliance with Korean Medical Devices Act requirements.